Kremlin Has No Data On Drug Labeling Failure

Kremlin Has No Data On Drug Labeling Failure
Kremlin Has No Data On Drug Labeling Failure

Video: Kremlin Has No Data On Drug Labeling Failure

Video: Labeling of pharmaceuticals in Russia. New Governmental Decrees 2022, November
Anonim

MOSCOW, October 23. / TASS /. The Kremlin has no information about a technical failure in the drug labeling system, Dmitry Peskov, the press secretary of the Russian president, told reporters.

Image
Image

"We do not have information about the details of this failure," he said and added that "it would be wrong for the Kremlin to come forward (in this situation) with any recommendations." "This is entirely a question of the government. It is necessary to address this question exactly there," said Peskov.

Earlier, the Pharmaceutical Bulletin reported that the Gedeon Richter Rus company was suspending the supply of medicines to Russia due to a technical failure in the system for monitoring the movement of medicines, which had been going on since September 30. The reason for this decision was the inability to carry out the customs procedure and sell drugs to participants in the distribution chain, the publication says. The company also announced its decision to the Ministry of Health, the Ministry of Industry and Trade, and Roszdravnadzor.

The drug labeling pilot project began on February 1, 2017. Mandatory labeling of drugs in the category of seven high-cost nosologies began on October 1, 2019. For other drugs, mandatory labeling began in July this year. Since the beginning of the experiment, the volume of labeled drugs introduced into civil circulation in Russia has exceeded 1 billion packages.

Popular by topic